TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19234845

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 30
Study: 17620776

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injection at 4 weeks after surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injection at 8 weeks after surgery
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) injection at 12 weeks after surgery
Number of subjects: 120

Group type: COMPARATOR
Intervention: Normal saline injection at 4 weeks after surgery (Control)
Number of subjects: 120
Study: 14982985

Group type: EXPERIMENTAL
Intervention: Furosemide 20 mg (2 mL)
Number of subjects: 12

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 12
Study: 11167437

Group type: EXPERIMENTAL
Intervention: 1 mg intrathecal diamorphine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.5 mg intrathecal diamorphine
Number of subjects: 40
Study: 9566833

Group type: EXPERIMENTAL
Intervention: Total paracentesis
Number of subjects: 46
Study: 7796796

Group type: EXPERIMENTAL
Intervention: Felbamate, titrated to a maximum daily dose of 3600 mg over 2 days
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 2351162

Group type: EXPERIMENTAL
Intervention: AAI-R pacing
Number of subjects: 40

Group type: COMPARATOR
Intervention: AAI pacing
Number of subjects: 40
Study: 520397

Group type: EXPERIMENTAL
Intervention: Propranolol 7.5, 15 and 30 mg i.v.
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Labetalol 30, 60 and 120 mg i.v.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both drugs (Propranolol and Labetalol)
Number of subjects: 8
Study: 30694752

Group type: EXPERIMENTAL
Intervention: Epinephrine in one‐per‐mil tumescent solution (1:1,000,000 epinephrine and 0.2% lidocaine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 12
Study: 28143679

Group type: EXPERIMENTAL
Intervention: Exercise intervention (12 weeks, twice per week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-exercise group activities (comparison condition)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 50
Study: 25875131

Group type: EXPERIMENTAL
Intervention: Combination of buried interrupted subcuticular sutures and adhesive strips
Number of subjects: 48

Group type: COMPARATOR
Intervention: Buried interrupted subcuticular sutures only
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 48
Study: 22898437

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 165

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Communication and coping skills training
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 165
Study: 21529314

Group type: EXPERIMENTAL
Intervention: Automatic CPAP (APAP)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Fixed CPAP
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: APAP
Number of subjects: 17
Study: 18480967

Group type: EXPERIMENTAL
Intervention: Immediate multilayer compression bandaging
Number of subjects: 69

Group type: COMPARATOR
Intervention: No bandaging (control)
Number of subjects: 69
Study: 17121193

Group type: EXPERIMENTAL
Intervention: Psychological treatment before dental procedures
Number of subjects: 100

Group type: COMPARATOR
Intervention: No psychological treatment before dental procedures
Number of subjects: 100
Study: 15597216

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 9000

Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 9000
Study: 11383811

Group type: EXPERIMENTAL
Intervention: Surgical sealant applied to sites at risk for air leak after standard methods of lung closure
Number of subjects: 172

Group type: COMPARATOR
Intervention: Standard lung closure only
Number of subjects: 172
Study: 9223200

Group type: COMPARATOR
Intervention: Intravenous saline (control group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 15 mg every 6 hours
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 30 mg every 6 hours
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketorolac added to PCA morphine on a milligram per milligram basis
Number of subjects: 80
Study: 7936530

Group type: EXPERIMENTAL
Intervention: Intraperitoneal lidocaine (80 mL of 0.5% lidocaine with 1/320,000 epinephrine and 10 mL of 2% lidocaine with 1/80,000 epinephrine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 50
Study: 3396547

Group type: EXPERIMENTAL
Intervention: General anaesthesia without suxamethonium
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Suxamethonium administration
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Re-application of the tourniquet after short reperfusion
Number of subjects: 34

Group type: COMPARATOR
Intervention: Pneumatic tourniquet application
Number of subjects: 34
Study: 30009652

Group type: EXPERIMENTAL
Intervention: Intradermal acupuncture (IA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham intradermal acupuncture (sham IA)
Number of subjects: 30
Study: 27184542

Group type: EXPERIMENTAL
Intervention: Pure Platelet-Rich Plasma (PRP) injection
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ropivacaine injection (control)
Number of subjects: 120
Study: 25512256

Group type: EXPERIMENTAL
Intervention: Supersaturated oxygen (SSO2) infusion via left main coronary artery (LMCA) for 60 minutes after primary percutaneous coronary intervention (PCI)
Number of subjects: 20
Study: 22898575

Group type: EXPERIMENTAL
Intervention: Nintendo Wii™-based motor cognitive training (10 Wii Fit™ games)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Balance exercise therapy (14 training sessions of stretching, strengthening, and balance training)
Number of subjects: 32
Study: 20821333

Group type: EXPERIMENTAL
Intervention: PrefCheck consultation guide
Number of subjects: 320

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 320
Study: 17890244

Group type: EXPERIMENTAL
Intervention: Everolimus and low-dose cyclosporine with early steroid avoidance (group A)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Low-dose steroid treatment (group B)
Number of subjects: 133
Study: 15938589

Group type: EXPERIMENTAL
Intervention: Glimepiride plus metformin (2 mg/day + 1500 mg/day)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Rosiglitazone plus metformin (4 mg/day + 1500 mg/day)
Number of subjects: 99
Study: 12823090

Group type: EXPERIMENTAL
Intervention: Olanzapine (2.5 mg/day, titrated to max 10 mg/day)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Risperidone (0.5 mg/day, titrated to max 2.0 mg/day)
Number of subjects: 39
Study: 10863887

Group type: EXPERIMENTAL
Intervention: Citalopram (40 mg per day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9001899

Group type: EXPERIMENTAL
Intervention: M.w vaccine (1 x 10(9) bacilli)
Number of subjects: 795

Group type: EXPERIMENTAL
Intervention: M.w vaccine (5 x 10(9) bacilli)
Number of subjects: 795

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 795
Study: 1461854

Group type: EXPERIMENTAL
Intervention: 6 cm incision
Number of subjects: 30

Group type: COMPARATOR
Intervention: 15 cm incision
Number of subjects: 30
Study: 6386694

Group type: EXPERIMENTAL
Intervention: Oxytetracycline
Number of subjects: 45

Group type: COMPARATOR
Intervention: Trimethoprim
Number of subjects: 45
Study: 30676816

Group type: EXPERIMENTAL
Intervention: UKtest
Number of subjects: 12
Study: 29253140

Group type: EXPERIMENTAL
Intervention: 120 g of retraction force
Number of subjects: 20

Group type: COMPARATOR
Intervention: 180 g of retraction force
Number of subjects: 20
Study: 26255618

Group type: EXPERIMENTAL
Intervention: Unilateral cochlear implantation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Bilateral cochlear implantation
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (pre-implantation)
Number of subjects: 38
Study: 25282679

Group type: EXPERIMENTAL
Intervention: Active scapular correction
Number of subjects: 23

Group type: COMPARATOR
Intervention: Passive scapular correction
Number of subjects: 23
Study: 22751877

Group type: EXPERIMENTAL
Intervention: Hypothermia treatment
Number of subjects: 127

Group type: COMPARATOR
Intervention: Normothermia
Number of subjects: 127
Study: 19597072

Group type: EXPERIMENTAL
Intervention: Modified directly observed therapy (mDOT) for 24 weeks
Number of subjects: 243

Group type: COMPARATOR
Intervention: Self-administered therapy
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Modified directly observed therapy (mDOT) for 48 weeks
Number of subjects: 243
Study: 17142385

Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg once daily
Number of subjects: 997

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice daily
Number of subjects: 997
Study: 15118192

Group type: EXPERIMENTAL
Intervention: Active Recovery (AR) - cycling at 40% VO(2peak) during a 15-min recovery period
Number of subjects: 7

Group type: COMPARATOR
Intervention: Passive Recovery (PR) - resting supine during a 15-min recovery period
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both AR and PR
Number of subjects: 7
Study: 11387501

Group type: EXPERIMENTAL
Intervention: All treatment groups combined
Number of subjects: 15116

Group type: EXPERIMENTAL
Intervention: All treatment groups combined (after adjustment for case mix)
Number of subjects: 15116
Study: 9738178

Group type: EXPERIMENTAL
Intervention: Commercially prepared solid foods from 3 to 12 months
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Parent's choice of solid foods from 3 to 12 months
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Commercially prepared solid foods from 6 to 12 months
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Parent's choice of solid foods from 6 to 12 months
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Early introduction of solid foods
Number of subjects: 165

Group type: COMPARATOR
Intervention: Late introduction of solid foods
Number of subjects: 165
Study: 7774451

Group type: EXPERIMENTAL
Intervention: Heparin solution (25U/ml) irrigated during operation
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no heparin solution)
Number of subjects: 47
Study: 3245859

Group type: EXPERIMENTAL
Intervention: 0.1% desonide cream
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.05% halometasone cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.05% clobetasol 17‐propionate cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.1% betamethasone 17‐valerate cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.05% clobetasone 17‐butyrate cream
Number of subjects: 0
Study: 29199540

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch (HES group, Tetraspan®)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Acetated Ringer's solution (CT group)
Number of subjects: 40
Study: 26473652

Group type: EXPERIMENTAL
Intervention: Pancreaticojejunostomy (PJ)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Stapler closure
Number of subjects: 136

Group type: COMPARATOR
Intervention: Stapler closure (subgroup analysis for thickness of pancreas > 12mm)
Number of subjects: 136
Study: 23900983

Group type: EXPERIMENTAL
Intervention: Cryobiopsy
Number of subjects: 39

Group type: COMPARATOR
Intervention: Forceps biopsy
Number of subjects: 39
Study: 22653816

Group type: EXPERIMENTAL
Intervention: Strictly-guided, station-based laboratory sessions
Number of subjects: 360

Group type: COMPARATOR
Intervention: Loosely-guided laboratory sessions
Number of subjects: 360
Study: 19866382

Group type: EXPERIMENTAL
Intervention: Self-regulated study (item selection and study time)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study time allocation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Study performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Memory self-efficacy and perceived control
Number of subjects: 0
Study: 18855180

Group type: EXPERIMENTAL
Intervention: Integrative reminiscence
Number of subjects: 106

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 106
Study: 16650239

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 89
Study: 14649617

Group type: EXPERIMENTAL
Intervention: Concise
Number of subjects: 120

Group type: COMPARATOR
Intervention: Optibond system
Number of subjects: 120

Group type: COMPARATOR
Intervention: Optibond system plus Concise
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Concise on wet saliva-contaminated surfaces
Number of subjects: 120
Study: 10821345

Group type: EXPERIMENTAL
Intervention: Angiotensin II antagonists (AIIA) monotherapy
Number of subjects: 11281

Group type: EXPERIMENTAL
Intervention: AIIA dose titration
Number of subjects: 11281

Group type: EXPERIMENTAL
Intervention: AIIA combined with low-dose hydrochlorothiazide (HCTZ)
Number of subjects: 11281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11281

Group type: COMPARATOR
Intervention: Other antihypertensive classes
Number of subjects: 11281
Study: 8629606

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (1-25 cigarettes per day)
Number of subjects: 348874

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (>= 26 cigarettes per day)
Number of subjects: 348874

Group type: COMPARATOR
Intervention: Age
Number of subjects: 348874

Group type: COMPARATOR
Intervention: Black race
Number of subjects: 348874

Group type: COMPARATOR
Intervention: Serum cholesterol (10 mg/dl higher)
Number of subjects: 348874
Study: 1452929

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Enalapril (10 mg) plus aspirin (350 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Enalapril (10 mg) with placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Enalapril (10 mg) without aspirin
Number of subjects: 18
Study: 3969190

Group type: EXPERIMENTAL
Intervention: Heparin (2,000 units) added to the second cycle
Number of subjects: 20
Study: 31349796

Group type: EXPERIMENTAL
Intervention: Supported Protocolized Discontinuation (SPD) and Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Supported Protocolized Discontinuation (SPD) alone
Number of subjects: 0
Study: 29603842

Group type: EXPERIMENTAL
Intervention: IVIg 1.0 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: IVIg 0.5 g/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: IVIg 2.0 g/kg
Number of subjects: 0
Study: 26764586

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: High emotion dysregulation
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Skills use
Number of subjects: 99
Study: 24309370

Group type: EXPERIMENTAL
Intervention: Etoposide plus cisplatin (n=129)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Irinotecan plus cisplatin (n=129)
Number of subjects: 258
Study: 22152080

Group type: EXPERIMENTAL
Intervention: Static handgrip exercise (HG)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Combined condition (HG + CPT)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Cold pressor test (CPT)
Number of subjects: 8
Study: 20458641

Group type: EXPERIMENTAL
Intervention: Anterolateral minimally invasive approach
Number of subjects: 44

Group type: COMPARATOR
Intervention: Modified direct lateral approach
Number of subjects: 44
Study: 17494679

Group type: EXPERIMENTAL
Intervention: Magnetization Transfer Ratio (MTR)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Whole-brain (WB) volume
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hippocampal (Hc) mean MTR
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Hippocampal (Hc) volume
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Histogram analysis of WB MTR
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Whole-brain (WB) volume and mean MTR
Number of subjects: 18
Study: 16683454

Group type: EXPERIMENTAL
Intervention: Total hip arthroplasty in patients with ankylosing spondylitis
Number of subjects: 13

Group type: COMPARATOR
Intervention: Total hip arthroplasty in patients with non-ankylosing spondylitis
Number of subjects: 13
Study: 12785624

Group type: EXPERIMENTAL
Intervention: Higher frequency tutoring (one 45‐min. session every 1.6 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lower frequency tutoring (one 45‐min. session every 8.3 days)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (higher and lower frequency)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Children with verbal ability scores one or two standard deviations below the population mean
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amount of work on sounding and blending drill
Number of subjects: 0
Study: 11077511

Group type: EXPERIMENTAL
Intervention: Lifestyle advice against smoking
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary advice (increased intake of grain products, vegetables, fruit, poultry, and fish)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Advice about exercise
Number of subjects: 0
Study: 8971230

Group type: EXPERIMENTAL
Intervention: Hydrotherapy
Number of subjects: 139

Group type: COMPARATOR
Intervention: Seated immersion
Number of subjects: 139

Group type: COMPARATOR
Intervention: Land exercise
Number of subjects: 139

Group type: COMPARATOR
Intervention: Progressive relaxation
Number of subjects: 139
Study: 1731030

Group type: EXPERIMENTAL
Intervention: Acellular diphtheria-tetanus-pertussis vaccine and Haemophilus influenzae type b conjugate vaccine given at separate injection sites
Number of subjects: 79

Group type: COMPARATOR
Intervention: Acellular diphtheria-tetanus-pertussis vaccine and Haemophilus influenzae type b conjugate vaccine given at a single site
Number of subjects: 79
Study: 3882356

Group type: EXPERIMENTAL
Intervention: 2 g of preoperatively applied ceftriaxon intravenously at the beginning of anesthesia
Number of subjects: 180

Group type: COMPARATOR
Intervention: No antibiotic at all (control group)
Number of subjects: 180
Study: 31899170

Group type: EXPERIMENTAL
Intervention: Low dose behavioral coaching (16 sessions over 24 months)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Moderate dose behavioral coaching (32 sessions over 24 months)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: High dose behavioral coaching (48 sessions over 24 months)
Number of subjects: 317

Group type: COMPARATOR
Intervention: Education-only comparator (16 sessions of nutrition education without coaching)
Number of subjects: 317
Study: 30991881

Group type: EXPERIMENTAL
Intervention: Water-based aerobic training (WA)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Water-based resistance training (WR)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 29231427

Group type: EXPERIMENTAL
Intervention: Contralateral acupuncture combined with rehabilitation training
Number of subjects: 74

Group type: COMPARATOR
Intervention: Rehabilitation training alone
Number of subjects: 74
Study: 25448092

Group type: EXPERIMENTAL
Intervention: AS03‐adjuvanted A/turkey/Turkey/1/05 H5N1 vaccine (3.75 or 7.5 μg HA)
Number of subjects: 841

Group type: COMPARATOR
Intervention: AS03A‐adjuvanted booster vaccine (3.75 μg HA)
Number of subjects: 841
Study: 23271615

Group type: EXPERIMENTAL
Intervention: Whole apples (550 g/day)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Apple pomace (22 g/day)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Cloudy apple juice (500 ml/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Clear apple juice (500 ml/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: No supplement
Number of subjects: 23
Study: 21586238

Group type: EXPERIMENTAL
Intervention: Artificial liver support system (plasma exchange combined with continuous veno-venous hemodiafiltration, PE + CVVHDF)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 81
Study: 18466617

Group type: EXPERIMENTAL
Intervention: Immediate exit cards
Number of subjects: 150

Group type: COMPARATOR
Intervention: Delayed telephone follow-up surveys
Number of subjects: 150
Study: 16594943

Group type: EXPERIMENTAL
Intervention: 5 mg/day donepezil
Number of subjects: 12
Study: 15329003

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 76
Study: 11087280

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (BT-A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9357934

Group type: EXPERIMENTAL
Intervention: 120-min infusion of 10 cal/oz formula
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 120-min infusion of 20 cal/oz formula
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Bolus feeding of 20 cal/oz formula over 15 min
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Water and half-strength formula as slow infusion
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Full-strength formula as slow infusion
Number of subjects: 14
Study: 1605959

Group type: EXPERIMENTAL
Intervention: Steroids + acyclovir (intravenous doses for Ramsay Hunt's syndrome)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Steroids (control group for Bell's palsy)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Acyclovir (oral doses for Bell's palsy)
Number of subjects: 45
Study: 4072592

Group type: EXPERIMENTAL
Intervention: Paracetamol 10 mg/kg
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Aminophenazone 4 mg/kg and Diazepam 0.2 mg/kg
Number of subjects: 82
Study: 29359279

Group type: EXPERIMENTAL
Intervention: High-dose baclofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28692770

Group type: EXPERIMENTAL
Intervention: Stopping TNFi
Number of subjects: 817

Group type: COMPARATOR
Intervention: Continuing TNFi
Number of subjects: 817
Study: 27157032

Group type: EXPERIMENTAL
Intervention: ASD load group
Number of subjects: 56

Group type: COMPARATOR
Intervention: ASD no load group
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: ASD load individuals
Number of subjects: 56